Brigham And Women's Hospital
Clinical trials sponsored by Brigham And Women's Hospital, explained in plain language.
-
Could a Vitamin-Like pill protect the brains of people with down syndrome?
Disease control Not yet recruitingThis early-stage trial tests a supplement called MIB-626 (a form of NMN) in 24 adults with Down syndrome. The goal is to see if it is safe and can raise NAD+ levels, which may help protect against Alzheimer's disease. Participants take the pill or a placebo for 28 days and are mo…
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Bladder cancer surgery: do stents help or hurt?
Disease control Not yet recruitingThis study looks at whether using ureteral stents (small tubes) after bladder cancer surgery leads to more or fewer problems than not using them. About 190 adults having their bladder removed will be randomly assigned to get stents or not. The main goal is to see who ends up back…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
One pill to lower it all: pharmacy nudges aim to simplify blood pressure treatment
Disease control Not yet recruitingThis study tests whether pharmacists can encourage doctors and patients to switch to a single pill that combines multiple blood pressure medicines. About 720 adults with high blood pressure will take part. The goal is to see if this approach helps lower blood pressure more effect…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Magic mushroom therapy targets heavy drinking in new trial
Disease control Not yet recruitingThis study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can help people with severe alcohol use disorder reduce heavy drinking. Thirty-six adults who recently completed detox will receive either a high or low dose of psilocybin du…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a single drug stop JAK2 mutations from turning into cancer?
Disease control Not yet recruitingThis pilot study tests whether the drug ropeginterferon is safe and feasible for 12 people with a JAK2 mutation and high-risk features who do not yet have a blood cancer. Participants receive an injection every 4 weeks and are monitored closely. The goal is to see if this approac…
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for cancer patients: Kidney-Sparing drug shows promise
Disease control Not yet recruitingThis study tests a drug called sparsentan to reduce high levels of protein in the urine (proteinuria) caused by certain cancer treatments. About 20 adults with cancer who are taking VEGF inhibitors and have developed proteinuria will receive sparsentan for 8 weeks. The goal is to…
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Sleep apnea combo therapy shows promise in early trial
Disease control Not yet recruitingThis study tests whether combining a nerve-stimulating implant with two medications (atomoxetine and oxybutynin) can improve breathing during sleep more than either treatment alone. Twenty-four adults with obstructive sleep apnea who already have the implant will try each combina…
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
AI assistant aims to boost heart failure drug use
Disease control Not yet recruitingThis study tests whether AI-generated messages can help doctors improve medication plans for adults with heart failure. About 500 patients will have their doctors receive brief suggestions before appointments. The goal is to see if more patients get the right medications within 3…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New seizure drug tested in ICU for emergency seizure control
Disease control Not yet recruitingThis early-phase study tests the drug cenobamate in 10 adults (ages 18–70) in the intensive care unit who are having frequent seizures or a prolonged seizure (status epilepticus). The goal is to see if cenobamate can quickly reach and maintain a target level in the blood, stop se…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could home hospital care keep dementia patients out of the ER?
Disease control Not yet recruitingThis study will test whether providing acute hospital care at home, instead of in a traditional hospital, can help people with moderate to severe dementia spend more days at home after an acute illness. Researchers will randomly assign 200 participants to either receive home-base…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Asthma showdown: which inhaler strategy wins?
Disease control Not yet recruitingThis study tests two ways to use asthma inhalers to prevent serious attacks. One strategy (MART) uses a combination inhaler for daily control and quick relief. The other (PARTICS) adds a separate steroid inhaler whenever a rescue inhaler is used. About 4,100 adults with moderate-…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a common heart drug reverse scarring in stiff heart failure?
Disease control Not yet recruitingThis study tests whether the drug sacubitril/valsartan can reduce scarring in the heart muscle of people with a type of heart failure called HFpEF (stiff heart). The trial will enroll 36 adults aged 50 and older with heart failure and a normal pumping function. Participants will …
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sound waves aimed at brain could ease severe OCD
Disease control Not yet recruitingThis study tests a non-invasive procedure that uses sound waves to target a small area in the brain thought to be involved in obsessive-compulsive disorder (OCD). It is for adults aged 25-64 with moderate to severe OCD that has not improved with standard treatments like therapy a…
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a sweetener beat a gut infection? new trial explores xylitol for c. diff in IBD
Disease control Not yet recruitingThis study tests if xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researchers …
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a diabetes drug curb cannabis cravings? small trial aims to find out
Disease control Not yet recruitingThis pilot study tests whether tirzepatide, a drug used for diabetes, can reduce cravings in people with severe cannabis use disorder. Six adults will receive either tirzepatide or a placebo injection and then be exposed to cannabis-related cues to measure craving intensity. The …
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a sweetener beat a gut infection? early trial tests xylitol for c. diff in IBD patients
Disease control Not yet recruitingThis pilot study tests whether xylitol, a common sugar alcohol, can safely clear C. difficile bacteria from the guts of people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take different doses of xylitol for up to 8 weeks. Researchers will…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
AI-Powered personalized care could transform opioid addiction treatment
Disease control Not yet recruitingThis study aims to create personalized treatment plans for people with opioid use disorder by using machine learning to find the best sequence of medications and behavioral therapy. Researchers will test these plans in a small pilot study with 75 adults to see if they are feasibl…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days and be followed fo…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Rwanda tests new way to diagnose breast cancer faster in rural areas
Diagnosis Not yet recruitingThis study looks at two ways to train non-radiologist doctors and nurses in rural Rwandan hospitals to perform breast ultrasound. The goal is to help women get diagnosed with breast cancer earlier, without having to travel to a big city hospital. About 1,792 women will take part,…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Smart mattress aims to stop nighttime epilepsy deaths
Prevention Not yet recruitingThis study tests the Korus smart mattress in 10 healthy adults to see if it can accurately detect body positions (like lying on the stomach) and automatically reposition the person to a safer side-lying position. The goal is to prevent sudden unexpected death in epilepsy (SUDEP) …
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Smart alerts aim to slash stroke risk in heart patients
Prevention Not yet recruitingThis study tests whether an electronic alert in doctors' computers can increase the use of blood thinners to prevent strokes in people with atrial fibrillation (an irregular heartbeat). About 2,500 high-risk patients who are not currently on blood thinners will take part. The goa…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
Lung cancer screening on wheels: bringing early detection to High-Risk neighborhoods
Prevention Not yet recruitingThis pilot study will bring a mobile lung cancer screening clinic to underserved neighborhoods in Boston. 125 high-risk adults (ages 50-80, current or former heavy smokers) will receive a low-dose CT scan and a video message to encourage future screening. The goal is to see if th…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Can chiropractic adjustments ease stubborn neck pain? new study aims to find out
Symptom relief Not yet recruitingThis pilot study will test whether adding chiropractic care (including spinal adjustments, massage, and exercises) to usual medical care helps adults with chronic neck pain. Sixty participants will be split into two groups: one gets chiropractic plus usual care, the other gets us…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New drug could slash opioid use after kidney stone surgery
Symptom relief Not yet recruitingThis study tests whether adding a new non-opioid painkiller called suzetrigine to standard pain management can reduce opioid use and complications after ureteroscopic surgery for kidney stones. About 100 adults aged 21-80 will receive either suzetrigine or placebo alongside usual…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a common gout pill ease pain from this rare joint disease?
Symptom relief Not yet recruitingThis study tests whether colchicine, a drug used for gout, can lower inflammation and pain in people with CPPD disease. About 150 adults will take either colchicine or a placebo daily for 6 months. Researchers will measure blood markers and joint symptoms to see if the drug helps…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Ear stimulation device could tame rosacea flushing
Symptom relief Not yet recruitingThis pilot study will test whether a device that gently stimulates a nerve in the ear (taVNS) can reduce facial redness and flushing in people with rosacea. Ten adults with moderate-to-severe rosacea will use the device daily for 4 weeks, then be followed for another 4 weeks to s…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
VR headsets take on migraine pain in new trial
Symptom relief Not yet recruitingThis study tests whether using a virtual reality headset to practice a type of mindfulness therapy called Acceptance and Commitment Therapy (ACT) can reduce migraine-related disability. About 160 adults with episodic migraine will either continue their usual care or add VR sessio…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Could a common steroid speed heart shock recovery?
Symptom relief Not yet recruitingThis study tests if giving a short course of steroids (methylprednisolone) for 7 days can help adults with heart failure who are in cardiogenic shock, a serious condition where the heart can't pump enough blood. The goal is to reduce harmful inflammation and help patients recover…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Brain scans vs tape measures: which TMS targeting works best for depression?
Symptom relief Not yet recruitingThis study tests whether using a person's brain scan (MRI) to guide TMS treatment for depression works better than the standard scalp-measurement method. 160 adults with major depression will receive accelerated TMS (10 sessions a day for 5 days) with either MRI or scalp targetin…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New app aims to boost wellness in blood cancer patients
Symptom relief Not yet recruitingThis study tests a digital app called WELL-MPN designed to help adults with myeloproliferative neoplasms (MPNs) improve their diet, physical activity, symptoms, and emotional well-being. About 75 participants will be randomly assigned to use the app or receive standard written li…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Belt vs. belt and suspenders: which stomach suture pattern wins for weight loss?
Symptom relief Not yet recruitingThis study tests if placing stitches only in the lower part of the stomach works as well as placing stitches in both the lower and upper parts for weight loss. Ten adults with obesity will get one of the two stitch patterns using a device called Endomina. Researchers will track h…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Your playlist as pain relief: new study tests music app for HIV-Related chronic pain
Symptom relief Not yet recruitingThis study tests whether a smartphone app that plays personalized music can help people with HIV manage chronic pain. Sixty participants will either use the music app daily for 3 months or receive educational materials about pain. The main goal is to see if the app is practical a…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could watching a movie replace multiple brain scans before surgery?
Knowledge-focused Not yet recruitingThis study compares a new type of brain scan—watching movie clips during functional MRI (fMRI)—to standard task-based fMRI for mapping language areas in people with brain tumors (gliomas). The goal is to see if the simpler movie-watching method works as well or better for helping…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Light on the neck and nose may calm stress, early study hints
Knowledge-focused Not yet recruitingThis study tests whether shining red/near-infrared light on the neck and inside the nose (called photobiomodulation) can improve how the body handles stress. Forty healthy adults will undergo a stressful test while wearing either a real or sham light device. Researchers will meas…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a phone buddy help caregivers of stem cell patients? new study aims to find out.
Knowledge-focused Not yet recruitingThis study tests whether a structured phone-based peer support program called STEPP-Care is practical and helpful for caregivers of people undergoing stem cell transplants. About 90 adult caregivers will be enrolled. The main goal is to see if at least 60% of participants complet…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Can a 'N-of-1' trial help heart failure patients find their perfect dose?
Knowledge-focused Not yet recruitingThis study tests a personalized approach to find the best beta-blocker dose for older adults with heart failure. Fifty participants will either receive the N-of-1 intervention (testing different doses in 2-week cycles) or enhanced usual care. The goal is to see if this patient-dr…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Exercise may unlock heart health secrets for seniors with hypertension
Knowledge-focused Not yet recruitingThis study looks at how a 12-week cardiac rehabilitation exercise program affects the heart and blood proteins in 42 older adults with high blood pressure who don't exercise regularly. Participants will be randomly assigned to either the exercise program or a control group that r…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Night shift metabolism: does sex matter?
Knowledge-focused Not yet recruitingThis study looks at whether being male or female changes how the body handles hunger and blood sugar when sleep and eating are out of sync, like during night shifts. Researchers will compare 36 healthy adults in a controlled lab setting. Results could lead to personalized shift s…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Opioid breathing risks during sleep under the microscope
Knowledge-focused Not yet recruitingThis study will give a single dose of morphine or a placebo to 26 adults (some healthy, some with obstructive sleep apnea) during a sleep study night. Researchers will measure how much their breathing changes. The goal is to understand why opioids can dangerously slow breathing d…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to help ugandan men open up about HIV
Knowledge-focused Not yet recruitingThis study is testing a new program to help men living with HIV in Uganda feel more comfortable telling their sexual partners about their HIV status. The program includes education, counseling, and practice conversations. Researchers want to see if it helps more men share their s…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Sleep loss may hit Women's blood sugar harder than Men's
Knowledge-focused Not yet recruitingThis study looks at whether not getting enough sleep affects blood sugar control differently in healthy men and women. Researchers will ask 32 adults to sleep only 4 hours a night for three nights and then measure their blood sugar and hormone responses after a meal. The goal is …
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC